People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Software / Tech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BioSig Technologies, Inc. | — | Software / Tech | Series A | $65.7M | $3.4M | 2014 |
| i-Lumen Scientific, Inc. | — | Other Health Care | Series B | $18.8M | $231.9M | 2020 |
Gregory Cash at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gregory Cash on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Gallagher | 1 | 11 |
| Jeffrey O'Donnell | 1 | 7 |
| Jerome Zeldis | 1 | 6 |
| Roy Tanaka | 1 | 6 |
| Kenneth Londoner | 1 | 5 |
| Anthony Zook | 1 | 4 |
| Stella Robertson | 1 | 4 |
| Asher Holzer | 1 | 4 |
| Patrick J. Gallagher | 1 | 4 |
| Samuel Navarro | 1 | 4 |
| Kalyanam Shivkumar | 1 | 3 |
| Greg Cash | 1 | 2 |
| Brian Mower | 1 | 2 |
| Michael Glover | 1 | 2 |
| Chris Pulling | 1 | 2 |
| Steve Chaussy | 1 | 2 |
| James J. Barry | 1 | 2 |
| Jay Schwartz | 1 | 2 |
| David Weild | 1 | 2 |
| Roy S Tanaka | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.